Blog

Note: This post originally appeared on AdvaMed.org on Oct. 30, 2020. View the original post here. AdvaMed Advance®

By Monish Rajpal, Jonas Funk and Ilya Trakhtenberg of L.E.K. Consulting In light of COVID-19, L.E.K. Consulting has

By Jim Welch, EY Global MedTech Leader, Health Sciences and Wellness On August 26, 2020, AdvaMed and EY

By Brian Chapman, Principal and Leader of ZS’s Medtech PracticeBrian Chapman is a principal in ZS’s Evanston office

by Richard Gliklich, MD, CEO of OM1 and Michelle Leavy, MPH, Head of Health Policy at OM1 Interest

By Susan Garfield, Principal at EY Due to COVID-19, stakeholders across the health care and life sciences industry

By The UK’s Department for International Trade  “In normal times, innovation is a very slow and ponderous process,

By Peter Shen, Global Head of Research & Development, Medical Devices, Johnson & Johnson While it’s true that

By Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices Living through a pandemic has put the importance

By Brian Chapman, Principal and Leader of ZS’s Medtech PracticeBrian Chapman is a principal in ZS’s Evanston office